Andrew Leber
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$5.9MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $5.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2026 | NIH | SBIR Phase I Immunometabolic Therapeutics for Alzheimer's Disease | $500K | Biotherapeutics, Inc. |
| Aug 24, 2026 | NIH | SBIR Phase I Immunometabolic Therapeutics for Multiple Sclerosis | $314K | Biotherapeutics, Inc. |
| Aug 4, 2025 | NIH | SBIR Phase II Novel Therapeutic for SLE | $314K | Biotherapeutics, Inc. |
| Jun 8, 2023 | NIH | SBIR Phase II Novel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus | $564K | Biotherapeutics, Inc. |
| Apr 15, 2023 | NIH | SBIR Phase I Immunoregulatory Therapeutics for Ulcerative Colitis | $356K | Biotherapeutics, Inc. |
| Jul 1, 2022 | NIH | SBIR Phase II Novel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus | $1.1M | Biotherapeutics, Inc. |
| Jun 4, 2021 | NIH | SBIR Phase II Validation of Immunometabolic NLRX1 Therapeutics for IBD | $643K | Biotherapeutics, Inc. |
| 2021 | NIH | SBIR Phase I Novel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus | $300K | Biotherapeutics, Inc. |
| Jul 1, 2020 | NIH | SBIR Phase I Developing Novel NLRX1-Based Immuno-Oncology Therapeutics | $231K | Biotherapeutics, Inc. |
| May 12, 2020 | NIH | SBIR Phase II Validation of Immunometabolic NLRX1 Therapeutics for IBD | $1.1M | Biotherapeutics, Inc. |
| May 1, 2020 | NIH | SBIR Phase I Novel Immunoregulatory Drugs for Type 1 Diabetes | $231K | Biotherapeutics, Inc. |
| Apr 1, 2019 | NIH | SBIR Phase I Immunometabolic NLRX1 Therapeutics for IBD | $233K | Biotherapeutics, Inc. |
Peer ranks
Federal funding#198
Awards as PI#86
Patents#273
Companies
- Biotherapeutics, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.